ASHPOfficial

ASHP Advantage: Beyond the Interaction Checker: A Deep Dive on Non-Traditional Drug Interactions with Immune Checkpoint Inhibitors

Does risk level “C” always mean “continue”? Join us as we delve into the current state of immune checkpoint inhibitor drug interaction reporting in common drug information resources and discuss how these interactions may be interpreted in daily clinical practice.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Advocating for Impact: Empowering Pharmacists to Treat Opioid Use Disorder

Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutics Thursday: Intrathecal Targeted Drug Delivery (ITDD) (C.E.)

Despite being developed in the late 1980s, Intrathecal pumps have been underutilized clinically for pain management for multiple reasons. With the opioid crisis and the significant increase in the proportion of the population with refractory pain, intrathecal pumps are gaining popularity.  Intrathecal pumps may be an appropriate option for improved pain control while minimizing side effects from systemic opioids.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Pharmacy: ASHP Advantage: Pharmacy Technician Development: Advancing the Career Trajectory

Learn from pharmacy technicians who lead technician education and training in their institutions as they discuss advancing pharmacy technician career development.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutics Thursday: Excipients, Preservatives, and Dyes in Children’s Medications

This episode will provide an overview of excipients and dyes used in medications that often consumed by children. Topics will include an overview of specific excipients and dyes, allergies vs intolerance to substances, and an explanation of regulatory oversight.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Pharmacy: ASHP Advantage: Can’t Touch This! Minimizing Hazardous Drug Exposures Across the Institution

This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutic Thursdays: Ketamine Use in Special (K) Populations - The Kritically Ill (C.E.)

Ketamine use for the dual purpose of sedation and analgesia in the critical care setting has been increasing dramatically. Ketamine has a unique pharmacologic mechanism of action that has been shown to be effective for various types of pain, sedation and other indications such as alcohol withdrawal, which are commonly seen in an intensive care setting.  This podcast with review basic pharmacology and dosing of ketamine and provide guidance on appropriate patient selection for ketamine use in the ICU.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Specialty Pharmacy: Navigating Specialty Pharmacy Accreditation Changes

In this episode, subject matter experts in health system organizations discuss the impact and changes in their organizations, due to accreditation updates in the specialty pharmacy space. This podcast is presented by members of the Accreditation and Compliance Section Advisory Group of the Section of Specialty Pharmacy Practitioners.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Practice Journeys: Career Pearls for Students: Pediatric Pharmacy

Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics: Compounding Conundrums: Compounding, what it IS and what it ISN’T

With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and extended stability. In this first episode of the series, listeners will review some of the definitions of compounding, how different regulating bodies define compounding, and how best to interpret these definitions in daily practice.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.